Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?

(MedPage Today) -- SAN DIEGO -- While using an endpoint of late-stage cancer incidence may be a suitable alternative to cancer-specific mortality for some cancers in screening trials, it doesn't work for others, researchers said here. A systematic...
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news